[Intolerance to hydroxychloroquine marketed in Spain (Dolquine) in patients with autoimmune conditions].
Jiménez-Alonso J, Sabio JM, Carrillo-Alascio PL, Jiménez-Jáimez J, Ortego-Centeno N, Jiménez-Jáimez E, Hidalgo-Tenorio C, Guzmán-Ubeda M, Jáimez L, Cáliz R, García-Sánchez A, Gallego M, Caminal L, Callejas-Rubio JL, Cervera R, Font J; Grupo LUPUS Virgen de las Nieves.
Jiménez-Alonso J, et al. Among authors: callejas rubio jl.
Rev Clin Esp. 2004 Nov;204(11):588-91. doi: 10.1157/13067369.
Rev Clin Esp. 2004.
PMID: 15511405
Clinical Trial.
Spanish.